Fund moves

Hims & Hers Health (HIMS): Farallon Capital Management, L.L.C. reduced its stake -3.38M shares

Farallon Capital Management, L.L.C. reduced its stake in Hims & Hers Health, per its Q1 2026 13F.

10K
Shares reported · -3.38M vs prior quarter
0.00%
Disclosed portfolio weight
$208K
Reported value
Holdings as of
Mar 31, 2026
Filed
Aug 14, 2026

What stands out in this filing

  • 3,386,986 shares in Q4 2025, 10,000 now (−99.7% in share count).
  • 4 other tracked managers reported the same kind of change for Q1 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 16, 2026InsiderOfficer sold ~$229K of HIMS shares in the open market
  2. Jun 17, 2026Insider · 3 peopleInsiders: 3 sales (~$1.5M)
  3. Jun 18, 2026Insider · 2 peopleInsiders: 2 sales (~$2.8M)
  4. Jun 22, 2026InsiderCFO sold ~$619K of HIMS shares in the open market
  5. Jun 26, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  6. Jul 6, 2026InsiderCFO sold ~$261K of HIMS shares in the open market
  7. Jul 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the “Company”) of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.”
  8. Jul 17, 2026InsiderCFO sold ~$229K of HIMS shares in the open market
  9. Aug 10, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Aug 17, 2026InsiderCFO sold ~$262K of HIMS shares in the open market
  2. Aug 18, 2026InsiderDirector sold ~$467K of HIMS shares in the open market
  3. Aug 19, 2026Insider · 2 peopleInsiders: 2 sales (~$840K)
  4. Sep 2, 2026InsiderOfficer sold ~$98K of HIMS shares in the open market
  5. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$624K)
  6. Sep 16, 2026InsiderOfficer sold ~$174K of HIMS shares in the open market
  7. Sep 17, 2026InsiderCFO sold ~$355K of HIMS shares in the open market
  8. Sep 22, 2026InsiderCFO sold ~$877K of HIMS shares in the open market
  9. Sep 30, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
  10. Oct 1, 2026InsiderCFO sold ~$59K of HIMS shares in the open market
  11. Oct 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the “Company”) as chief accounting officer. On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective October 9, 2026, concurrently with the previously disclosed resignation of Irene Becklund as the Company's principal accounting officer.”
  12. Oct 14, 2026InsiderOfficer sold ~$101K of HIMS shares in the open market
  13. Oct 28, 2026InsiderOfficer sold ~$96K of HIMS shares in the open market
  14. Oct 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 5.0%
  15. Nov 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 4, 2026, the board of directors (the “Board”) of Hims & Hers Health, Inc. (the “Company”) increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorship, effective immediately.”
  16. Nov 9, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  17. Nov 16, 20265% stakeG1 Execution Services, LLC reported a passive stake (13G) of 4.8%
  18. Nov 17, 2026Insider · 3 peopleInsiders: 3 sales (~$571K)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Hims & Hers Health

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIMS page.

How this filing works

Explore the data

Common questions

What does this filing report about Hims & Hers Health (HIMS) stock?

Farallon Capital Management, L.L.C. reduced its stake in Hims & Hers Health, per its Q1 2026 13F. Now 10K shares, $208K reported value, 0.00% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: Aug 14, 2026.

What stands out in this filing?

3,386,986 shares in Q4 2025, 10,000 now (−99.7% in share count). 4 other tracked managers reported the same kind of change for Q1 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Hims & Hers Health recently?

For Hims & Hers Health, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the HIMS page.

Does this mean HIMS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Hims & Hers Health

Everything OQRO holds on this company is on its HIMS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data